Tumor necrosis factor-beta is associated with thymic apoptosis during acute rejection.
BACKGROUND
Intrathymic events undergoing allograft rejection remain undefined. The present study investigated the role of tumor necrosis factor-beta on acute thymic involution in rat hepatic allograft recipients during rejection.


METHODS
Apoptosis and cellular phenotypic changes in the thymus were studied after hepatic transplantation.


RESULTS
Thymocytes in both the medulla and cortex were sparse during acute rejection. Phenotypically, CD4+CD8+ T cells decreased significantly, whereas there were relative increases in CD4-CD8-, CD4+CD8-, and CD4-CD8+ T cells in untreated allograft recipients. Additionally, thymic apoptosis was found by in situ DNA end labeling and electron microscopy. Apoptotic cells were predominantly distributed in the cortex. Biologic lymphotoxin (tumor necrosis factor-beta)/tumor necrosis factor-alpha cytotoxic activity in the serum was significantly increased in untreated hepatic allograft recipients. Tumor necrosis factor-beta mRNA was detected in untreated allograft livers, and intraperitoneal administration of recombinant human tumor necrosis factor-beta induced extensive apoptosis of thymocytes in vivo. In contrast, no significant thymic involution was observed in donor-specific blood transfusion-treated allograft and isograft recipients. Intraperitoneal administration of rabbit anti-human tumor necrosis factor-beta polyclonal antibody or recombinant human interleukin-10 inhibited thymic apoptosis in untreated hepatic allograft recipients.


CONCLUSIONS
Allograft rejection, but not donor-specific transfusion-induced immunologic unresponsiveness, is associated with thymic involution, a process that may be mediated by tumor necrosis factor-beta.
Yamaguchi
Y
Y
Department of Surgery II, Kumamoto University Medical School, Honjo, Japan.
Okabe
K
K
Miyanari
N
N
Matsumura
F
F
Ichiguchi
O
O
Akizuki
E
E
Matsuda
T
T
Liang
J
J
Ohshiro
H
H
Miyayama
Y
Y
Yamada
S
S
Mori
K
K
Ogawa
M
M
D000208:Acute Disease; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D048429:Cell Size; D005434:Flow Cytometry; D006084:Graft Rejection / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics; D016031:Liver Transplantation; D008233:Lymphotoxin-alpha / Q000235:genetics / Q000378:metabolism*; D008297:Male; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D011912:Rats, Inbred ACI; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013950:Thymus Gland / Q000473:pathology / Q000503:physiopathology*
D008233:Lymphotoxin-alpha; D012333:RNA, Messenger; D016753:Interleukin-10